A beta cell subset with enhanced insulin secretion and glucose metabolism is reduced in type 2 diabetes. Academic Article uri icon

Overview

abstract

  • The pancreatic islets are composed of discrete hormone-producing cells that orchestrate systemic glucose homeostasis. Here we identify subsets of beta cells using a single-cell transcriptomic approach. One subset of beta cells marked by high CD63 expression is enriched for the expression of mitochondrial metabolism genes and exhibits higher mitochondrial respiration compared with CD63lo beta cells. Human and murine pseudo-islets derived from CD63hi beta cells demonstrate enhanced glucose-stimulated insulin secretion compared with pseudo-islets from CD63lo beta cells. We show that CD63hi beta cells are diminished in mouse models of and in humans with type 2 diabetes. Finally, transplantation of pseudo-islets generated from CD63hi but not CD63lo beta cells into diabetic mice restores glucose homeostasis. These findings suggest that loss of a specific subset of beta cells may lead to diabetes. Strategies to reconstitute or maintain CD63hi beta cells may represent a potential anti-diabetic therapy.

publication date

  • March 16, 2023

Research

keywords

  • Diabetes Mellitus, Experimental
  • Diabetes Mellitus, Type 2
  • Insulin-Secreting Cells

Identity

PubMed Central ID

  • PMC10449536

Scopus Document Identifier

  • 85150045044

Digital Object Identifier (DOI)

  • 10.1038/s41556-023-01103-1

PubMed ID

  • 36928765

Additional Document Info

volume

  • 25

issue

  • 4